New Haven pharmaceutical company Alexion to lay off more than 200 employees

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

NEW HAVEN — A Connecticut pharmaceutical company has announced it plans to lay off more than 200 employees in the coming weeks.

The New Haven Register reports that a spokeswoman for Alexion Pharmaceuticals said Monday that the 210 layoffs represent about 7 percent of Alexion’s 3,000-person workforce.

The biopharmaceutical company, which makes drugs to treat rare diseases, says the move aims to help position the company for “sustainable, long-term growth.” It’s unclear where the layoffs are being made.

The New Haven company announced in 2012 that it would be relocating from Cheshire. It accepted incentives from the state as part of its First Five economic development program.

Officials with the state Department of Economic and Community Development weren’t immediately available for comment Tuesday.

Alexion has a manufacturing facility in Smithfield, Rhode Island.

In December, Ridgefield-based Boehringer Ingelheim notified 180 local employees that they will be laid off.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.